Related references
Note: Only part of the references are listed.Cerebrolysin Enhances Neurogenesis in the Ischemic Brain and Improves Functional Outcome After Stroke
Chunling Zhang et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2010)
Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesis
Lina Yao et al.
NATURE MEDICINE (2010)
Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant
Samantha Perez-Miller et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Suppression of Heavy Drinking and Alcohol Seeking by a Selective ALDH-2 Inhibitor
Maria P. Arolfo et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2009)
High resolution analysis of the human transcriptome: detection of extensive alternative splicing independent of transcriptional activity
Weiyin Zhou et al.
BMC GENETICS (2009)
Proteome analysis of human substantia nigra in Parkinson's disease
Cornelius J. Werner et al.
PROTEOME SCIENCE (2008)
Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart
Che-Hong Chen et al.
SCIENCE (2008)
Aggregation of α-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine
William J. Burke et al.
ACTA NEUROPATHOLOGICA (2008)
Retinaldehyde represses adipogenesis and diet-induced obesity
Ouliana Ziouzenkova et al.
NATURE MEDICINE (2007)
MolDock: A new technique for high-accuracy molecular docking
Rene Thomsen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Toxicity and detoxification of lipid-derived aldehydes in cultured retinal pigmented epithelial cells
S Choudhary et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia
D Galter et al.
NEUROBIOLOGY OF DISEASE (2003)
Contributions to the binding free energy of ligands to avidin and streptavidin
T Lazaridis et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2002)
Share Paper
